Members Wealth’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$483K Hold
66,763
– – 0.24% 67
2026
Q2
$436K Buy
66,763
+36,763
+123% +$175K 0.24% 69
2026
Q1
$127K Hold
30,000
– – 0.08% 112
2025
Q4
$153K Buy
+30,000
New +$131K 0.1% 106

Other funds holding ACHV

Members Wealth's ACHV Position: Q3 2026 in Review

Members Wealth held its Achieve Life Sciences (ACHV) position steady in Q3 2026 at 66,763 shares worth $483K. The position accounts for 0.24% of the portfolio, ranked #67.

Members Wealth first reported a position in ACHV in Q4 2025 and has held it in 4 quarters since. 17 funds tracked by Wall St. Rank hold ACHV as of Q3 2026.

  • Members Wealth held 66,763 shares of Achieve Life Sciences worth $483K as of Q3 2026.
  • Members Wealth left its Achieve Life Sciences share count unchanged in Q3 2026.
  • Achieve Life Sciences made up 0.24% of Members Wealth's portfolio in Q3 2026, its #67 holding.
  • Members Wealth first reported a position in Achieve Life Sciences in Q4 2025 and has held it in 4 quarters since.
  • 17 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Members Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.